Stock AXDX ACCELERATE DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Accelerate Diagnostics, Inc.

Equities

AXDX

US00430H2013

Real-time Estimate Cboe BZX
Other stock markets
 10:36:06 2024-04-19 am EDT 		5-day change 1st Jan Change
0.782 USD +1.56% Intraday chart for Accelerate Diagnostics, Inc. -7.67% -79.08%
Mar. 29 Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 28 Transcript : Accelerate Diagnostics, Inc., Q4 2023 Earnings Call, Mar 28, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Certain Warrants of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
CI
Certain Restricted Stock Units of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
CI
Certain Common Stock of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
CI
Certain Stock Options of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
CI
Accelerate Diagnostics : Announces 510(k) Submission of the Accelerate Arc™ System to the FDA
PU
Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Accelerate Diagnostics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
PR
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results
AQ
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
PR
Accelerate Diagnostics, Inc. announced that it expects to receive $4.749996 million in funding from Jack W. Schuler Living Trust
CI
Top Midday Decliners
MT
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
PR
Sector Update: Health Care Stocks Weaker Late Afternoon
MT
Sector Update: Health Care
MT
Top Midday Decliners
MT
Accelerate Diagnostics Announces Launch of Proposed Public Offering
PR
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
PR
Accelerate Diagnostics, Inc. Announces Preliminary Unaudited Revenue Results for the Year Ended December 31, 2023
CI
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination with Bruker's MALDI Biotyper
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AXDX Stock
  4. News Accelerate Diagnostics, Inc.